136 related articles for article (PubMed ID: 17976664)
1. The effects of lamotrigine on alcohol seeking and relapse.
Vengeliene V; Heidbreder CA; Spanagel R
Neuropharmacology; 2007 Dec; 53(8):951-7. PubMed ID: 17976664
[TBL] [Abstract][Full Text] [Related]
2. Metabolic shift of the kynurenine pathway impairs alcohol and cocaine seeking and relapse.
Vengeliene V; Cannella N; Takahashi T; Spanagel R
Psychopharmacology (Berl); 2016 Sep; 233(18):3449-59. PubMed ID: 27475106
[TBL] [Abstract][Full Text] [Related]
3. The effects of xenon and nitrous oxide gases on alcohol relapse.
Vengeliene V; Bessiere B; Pype J; Spanagel R
Alcohol Clin Exp Res; 2014 Feb; 38(2):557-63. PubMed ID: 24118055
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of guanfacine as a potential medication for alcohol use disorder in long-term drinking rats: behavioral and electrophysiological findings.
Fredriksson I; Jayaram-Lindström N; Wirf M; Nylander E; Nyström E; Jardemark K; Steensland P
Neuropsychopharmacology; 2015 Mar; 40(5):1130-40. PubMed ID: 25359257
[TBL] [Abstract][Full Text] [Related]
5. The Calpain Inhibitor A-705253 Attenuates Alcohol-Seeking and Relapse with Low Side-Effect Profile.
Vengeliene V; Moeller A; Meinhardt MW; Beardsley PM; Sommer WH; Spanagel R; Bespalov A
Neuropsychopharmacology; 2016 Mar; 41(4):979-88. PubMed ID: 26216521
[TBL] [Abstract][Full Text] [Related]
6. Effects of GABA(B) receptor agents on cocaine priming, discrete contextual cue and food induced relapses.
Filip M; Frankowska M
Eur J Pharmacol; 2007 Oct; 571(2-3):166-73. PubMed ID: 17610868
[TBL] [Abstract][Full Text] [Related]
7. The role of the NMDA receptor in alcohol relapse: a pharmacological mapping study using the alcohol deprivation effect.
Vengeliene V; Bachteler D; Danysz W; Spanagel R
Neuropharmacology; 2005 May; 48(6):822-9. PubMed ID: 15829254
[TBL] [Abstract][Full Text] [Related]
8. The dopamine D3 receptor plays an essential role in alcohol-seeking and relapse.
Vengeliene V; Leonardi-Essmann F; Perreau-Lenz S; Gebicke-Haerter P; Drescher K; Gross G; Spanagel R
FASEB J; 2006 Nov; 20(13):2223-33. PubMed ID: 17077299
[TBL] [Abstract][Full Text] [Related]
9. Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol preferring rats chronically treated with lamotrigine.
Zalewska-Kaszubska J; Bajer B; Gorska D; Andrzejczak D; Dyr W; Bieńkowski P
Physiol Behav; 2015 Feb; 139():7-12. PubMed ID: 25449391
[TBL] [Abstract][Full Text] [Related]
10. Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system.
Cannella N; Economidou D; Kallupi M; Stopponi S; Heilig M; Massi M; Ciccocioppo R
Neuropsychopharmacology; 2009 Aug; 34(9):2125-34. PubMed ID: 19322167
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse.
Feltenstein MW; Altar CA; See RE
Biol Psychiatry; 2007 Mar; 61(5):582-90. PubMed ID: 16806092
[TBL] [Abstract][Full Text] [Related]
12. The GABA(B) receptor allosteric modulator CGP7930, like baclofen, reduces operant self-administration of ethanol in alcohol-preferring rats.
Liang JH; Chen F; Krstew E; Cowen MS; Carroll FY; Crawford D; Beart PM; Lawrence AJ
Neuropharmacology; 2006 Apr; 50(5):632-9. PubMed ID: 16406445
[TBL] [Abstract][Full Text] [Related]
13. Development of an alcohol deprivation and escalation effect in C57BL/6J mice.
Melendez RI; Middaugh LD; Kalivas PW
Alcohol Clin Exp Res; 2006 Dec; 30(12):2017-25. PubMed ID: 17117967
[TBL] [Abstract][Full Text] [Related]
14. The use of a novel drinkometer system for assessing pharmacological treatment effects on ethanol consumption in rats.
Vengeliene V; Noori HR; Spanagel R
Alcohol Clin Exp Res; 2013 Jan; 37 Suppl 1():E322-8. PubMed ID: 22757984
[TBL] [Abstract][Full Text] [Related]
15. Effects of alcohol deprivation on alcohol consumption using a sipper-tube procedure.
Samson HH; Chappell A
Alcohol Clin Exp Res; 2001 May; 25(5):680-6. PubMed ID: 11371717
[TBL] [Abstract][Full Text] [Related]
16. SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats.
de Bruin NM; Lange JH; Kruse CG; Herremans AH; Schoffelmeer AN; van Drimmelen M; De Vries TJ
Behav Brain Res; 2011 Mar; 217(2):408-15. PubMed ID: 21074574
[TBL] [Abstract][Full Text] [Related]
17. mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior.
Bäckström P; Bachteler D; Koch S; Hyytiä P; Spanagel R
Neuropsychopharmacology; 2004 May; 29(5):921-8. PubMed ID: 14735132
[TBL] [Abstract][Full Text] [Related]
18. The metabotropic glutamate 2/3 receptor agonist LY404039 reduces alcohol-seeking but not alcohol self-administration in alcohol-preferring (P) rats.
Rodd ZA; McKinzie DL; Bell RL; McQueen VK; Murphy JM; Schoepp DD; McBride WJ
Behav Brain Res; 2006 Aug; 171(2):207-15. PubMed ID: 16678921
[TBL] [Abstract][Full Text] [Related]
19. Distinct patterns of neural activation associated with ethanol seeking: effects of naltrexone.
Dayas CV; Liu X; Simms JA; Weiss F
Biol Psychiatry; 2007 Apr; 61(8):979-89. PubMed ID: 17098214
[TBL] [Abstract][Full Text] [Related]
20. The metabotropic glutamate 5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine reduces ethanol self-administration in multiple strains of alcohol-preferring rats and regulates olfactory glutamatergic systems.
Cowen MS; Djouma E; Lawrence AJ
J Pharmacol Exp Ther; 2005 Nov; 315(2):590-600. PubMed ID: 16014750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
